- authorisedTherapeutic exploratory (Phase II)
RENAISSANCE 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures
This study is testing a new medicine, SPN-817, for adults who have focal onset seizures. We want to see if it helps reduce seizures and if it's safe. Some people will get the new medicine, and others will get a dummy medicine to compare the effects.
Poland · Hungary · Bulgaria - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
This study is testing a new medicine, XEN1101, for people with focal-onset seizures. It aims to see if the drug can reduce the number of seizures people have compared to a dummy pill. This is a large study to make sure the medicine is safe and works well.
Spain · Poland · Bulgaria - recruitingPHASE3
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
This study is testing a new medicine, XEN1101, for people with focal-onset seizures to see if it helps reduce seizures and is safe. Some people will get the real medicine, and others a dummy pill. It's for adults (18+) who already take seizure medicine.
United States · Argentina · Australia